Documents Statin Landmark Trials Across the Spectrum of Risk: Secondary CV Prevention

Slide 1 Statin Landmark Trials Across the Spectrum of Risk: Secondary CV Prevention 1 TNT: Study Design Treating to New Targets 2 5 years 10,001 Patients Clinically evident…